Anti-Xa activity after subcutaneous administration of dalteparin in ICU patients with and without subcutaneous oedema: a pilot study

M.K. Rommers, N. van der Lely, A.C.G. Egberts, P.M.L.A. van den Bemt

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
JournalCritical Care
Volume10
Publication statusPublished - 2006

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this